SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Cardiology Consultation — Benny Leonard
| Patient | Benny Leonard |
|---|
| Date of birth | 1976-04-07 |
|---|
| Identifiers | MRN HR-BX008-SYN; SSN (made up) 000-08-4106 |
|---|
| Document date | 2026-05-26 |
|---|
| Author | Daniel Achebe-Lindqvist, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
A 50-year-old professional boxing referee and boxing instructor with newly found stage 2 hypertension, left ventricular hypertrophy by voltage on the ECG, and two months of breathlessness and chest tightness late in long nights of refereeing in hot arenas. Please evaluate the symptoms and the hypertrophy, advise on his coronary and sudden cardiac death risk, and say whether and how he can keep refereeing. [S]
Urgency: Soon, within two weeks; he is refereeing only short undercards until seen. [S]
Questions for the consultant:
- Are his exertional breathlessness and chest tightness ischemic, and what test do you advise?
- Is the left ventricular hypertrophy from hypertension, or could it be hypertrophic cardiomyopathy or an athlete's heart?
- What is his risk of sudden cardiac death, and does he need ambulatory monitoring or other testing?
- Would a coronary calcium score help decide on a statin and aspirin, and what do you recommend?
- Can he keep refereeing, which means hours of moving about the ring in hot arenas, and with what precautions?
History of Present Illness
Mr. Leonard, 50, a professional boxing referee and boxing instructor, is seen at the request of Dr. Okafor-Rosenthal two weeks after stage 2 hypertension was found at his license examination. For about two months he has had breathlessness and chest tightness late in long nights of refereeing in hot arenas, easing with a few minutes' rest; none at rest, no fainting or palpitations. Since starting losartan-hydrochlorothiazide two weeks ago he has refereed only undercards and has had no symptoms. He never smoked. His family history is not known. He asked whether he will lose his license. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Benjamin Leiner was born on April 7, 1896, in New York City, to Gershon Leiner, a tailor, and Minnie Leiner, Orthodox Jewish immigrants from Russia, and grew up on the Lower East Side of Manhattan. [D]
- He began fighting professionally at about fifteen and took the name Benny Leonard to keep his boxing secret from his parents, because boxing was not thought a respectable living in their community. [D]
- He won the world lightweight championship from Freddie Welsh on May 28, 1917, and held it until he retired as undefeated champion in January 1925, at his mother's wish. [D]
- The son of Orthodox Jews, he never fought on a Jewish holiday and became a symbol of the acceptance of Jews in American life at a time of open antisemitism; the newspaper editor Arthur Brisbane wrote that he had done more to conquer anti-Semitism than a thousand textbooks. He later supported the Maccabiah Games. [D]
- Retired, he had become wealthy; in his own words he was practically a millionaire, without a scratch. [D]
- He lost most of his savings in the 1929 stock market crash and in October 1931, at 35, came back as a welterweight; he won about nineteen fights in a row before Jimmy McLarnin knocked him out in the sixth round in October 1932, and he retired for good. [D]
- During the Second World War he served in the U.S. Maritime Service of the Merchant Marine, rising to lieutenant commander. [D]
- He returned to boxing as a referee of professional bouts in New York and also taught boxing at City College of New York. [D]
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Losartan 50 mg with hydrochlorothiazide 12.5 mg, one tablet each morning | One tablet each morning | Oral route | 2026-05-12 to 2026-06-30 | completed | S |
| Atorvastatin 40 mg tablet, one each evening | One tablet each evening | Oral route | 2026-05-26 | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Breathlessness and tightness across the chest on exertion for about two months, late in long nights of refereeing in hot arenas, easing within a few minutes of rest; never at rest; no fainting, palpitations, orthopnea or ankle swelling; cause under evaluation with a cardiology consultation | resolved | confirmed |
R06.09 | S — Synthetic presenting problem anchored to his documented work as a referee; superseded at the consultation when stress testing showed no ischemia and the symptom was attributed to hypertensive heart disease. |
| Stage 2 hypertension found at a yearly fitness examination for his referee's license (164/100 and 160/98 mmHg), with left ventricular hypertrophy by voltage on the ECG; untreated; home readings to follow | resolved | confirmed |
I10 | S — Synthetic diagnosis at intake; reclassified as hypertensive heart disease after the echocardiogram at the consultation. |
| Hypertensive heart disease without heart failure: concentric left ventricular hypertrophy (septum 13 mm, mass index 118 g/m2) with normal ejection fraction, grade 1 diastolic dysfunction, a mildly enlarged left atrium and an exaggerated blood pressure rise on exercise; no features of hypertrophic cardiomyopathy | active | confirmed |
I11.9 | S — Synthetic diagnosis made at the cardiology consultation; not a claim about his real heart. |
| Coronary atherosclerosis found by coronary calcium scoring (Agatston score 186, about the 80th percentile for his age and sex), without angina and with no inducible ischemia on exercise stress echocardiography | active | confirmed |
I25.10 | S — Synthetic diagnosis made at the cardiology consultation; not a retrospective diagnosis of the cause of his death, which is disputed. |
| Hypercholesterolemia: LDL 160 mg/dL, HDL 44 mg/dL, lipoprotein(a) not raised; no diabetes | active | confirmed |
E78.00 | S — Synthetic diagnosis at intake. |
Physical Exam
Vital signs recorded on 2026-05-26; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|
| General | Lean, fit-looking man; blood pressure 148/92 mmHg, pulse 74 and regular |
| Cardiac | Sustained, undisplaced apex beat; fourth heart sound; no murmur at rest, with Valsalva or on standing; no rub |
| Vascular | No carotid or femoral bruits; foot pulses normal; no radio-femoral delay |
| Lungs and extremities | Clear lungs; no edema |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-05-26 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-146 mmol/L | Normal | S |
| 2026-05-26 | Potassium [Moles/volume] in Serum or Plasma | 4 | mmol/L | 3.5-5.3 mmol/L | Normal | S |
| 2026-05-26 | Urea nitrogen [Mass/volume] in Serum or Plasma | 16 | mg/dL | 7-25 mg/dL | Normal | S |
| 2026-05-26 | Creatinine [Mass/volume] in Serum or Plasma | 1.04 | mg/dL | 0.7-1.3 mg/dL | Normal | S |
| 2026-05-26 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 87 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-05-26 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 65-99 mg/dL | Normal | S |
| 2026-05-26 | Left ventricular Ejection fraction | 62 | % | 52-72% | Normal | S |
| 2026-05-26 | Interventricular septum Thickness during diastole by US | 13 | mm | 6-10 mm | High | S |
| 2026-05-26 | Left ventricular Myocardial mass/Body surface area [Mass/Area] by US 2D | 118 | g/m2 | 49-115 g/m2 | High | S |
| 2026-05-26 | Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area | 36 | mL/m2 | 16-34 mL/m² | High | S |
Assessment
- Exertional breathlessness and chest tightness (R06.09). Not ischemic. An exercise stress echocardiogram was chosen because it tests for ischemia, measures his working capacity and shows the blood pressure response to effort; it showed no inducible ischemia at about 10.5 METs. The symptoms are best explained by a steep rise in blood pressure on exertion (to 226/98 mmHg) in a thickened, stiff ventricle, made worse by heat; they should settle as blood pressure is controlled. [S]
- Type of hypertrophy (I11.9). Hypertensive heart disease. The hypertrophy is concentric and modest (septum 13 mm, septal-to-posterior ratio 1.1) with no systolic anterior motion, no outflow gradient, a normal-sized cavity and diastolic dysfunction, in a man with stage 2 hypertension; this fits hypertension and not hypertrophic cardiomyopathy, and an athlete's heart is unlikely at 50 years and years after competitive training. If the hypertrophy does not regress after six to twelve months of good control, or a family history emerges, cardiac MRI would be the next test. [S]
- Sudden cardiac death risk (I11.9). Left ventricular hypertrophy raises the risk of sudden cardiac death, and controlling blood pressure lowers it as the hypertrophy regresses. He has no fainting, palpitations or arrhythmia on exercise, a normal ejection fraction and a normal QTc, so ambulatory ECG monitoring and an implantable defibrillator are not indicated; monitoring would be needed for palpitations or fainting. Potassium should be kept in the normal range on the diuretic. He should know the warning symptoms, and the venues where he works should have a defibrillator at ringside and staff trained in CPR. [S]
- Coronary calcium, statin and aspirin (I25.10). A coronary calcium score of 186, above 100 and about the 80th percentile, shows coronary atherosclerosis and favors a statin: atorvastatin 40 mg, aiming for LDL below 70 mg/dL and a fall of at least 50%, with a lipid panel at eight to twelve weeks. Low-dose aspirin may be considered with a score over 100, but not while blood pressure is uncontrolled because of the bleeding risk; it should be revisited as a shared decision once blood pressure is at goal. Routine repeat stress testing is not recommended without new symptoms. [S]
- Refereeing (I11.9). He can keep refereeing. Until home blood pressure is below 140/90 mmHg, short undercards only; then full cards. Drink water between bouts, especially in hot arenas; stop and hand over a bout for chest discomfort, faintness or palpitations; hold the blood pressure tablet on sick days. A thiazide can deplete salt and water in a man who sweats heavily at work; if that happens, losartan with amlodipine is a good alternative. The target is below 130/80 mmHg, and the dose of losartan-hydrochlorothiazide can be raised at the next review if he is not there. [S]
Data reviewed: Dr. Okafor-Rosenthal's intake note, ECG and laboratory tests. Home readings over the past week averaged 146/92 mmHg. Basic metabolic panel today: sodium 139, potassium 4.0 mmol/L, creatinine 1.04 mg/dL. Transthoracic echocardiogram today: concentric left ventricular hypertrophy (septum 13 mm, posterior wall 12 mm, mass index 118 g/m2), ejection fraction 62%, grade 1 diastolic dysfunction, left atrial volume index 36 mL/m2, no systolic anterior motion or outflow obstruction at rest or with Valsalva, normal valves and aortic root. Exercise stress echocardiogram today (Bruce): 9 minutes 30 seconds, about 10.5 METs, peak heart rate 156 per minute (92% of predicted), blood pressure 150/92 rising to 226/98 mmHg, mild breathlessness at peak without chest discomfort, no ST change, no arrhythmia, normal wall augmentation. Coronary calcium CT today: Agatston 186 (left anterior descending 118, right coronary 52, circumflex 16), about the 80th percentile for his age and sex. [S]
Plan of Treatment
- Continue losartan 50 mg with hydrochlorothiazide 12.5 mg; raise the dose if home readings stay above 130/80 mmHg; basic metabolic panel after each change. [S]
- If the thiazide causes volume depletion or low potassium in the heat, change to losartan with amlodipine. [S]
- Atorvastatin 40 mg each evening; lipid panel at eight to twelve weeks; LDL goal below 70 mg/dL. [S]
- No aspirin until blood pressure is controlled; then revisit it as a shared decision. [S]
- No ambulatory ECG monitoring or defibrillator now; monitoring for any palpitations or fainting; no routine repeat stress testing. [S]
- Short undercards until home blood pressure is below 140/90 mmHg, then full cards, with water between bouts and the warning symptoms explained; a defibrillator and CPR-trained staff at ringside. [S]
- Repeat echocardiogram six to twelve months after today to judge regression; cardiac MRI if the hypertrophy does not regress. [S]
- Discussed with Dr. Okafor-Rosenthal, who saw him the same day. Mr. Leonard was told that his heart arteries are not narrowed enough to cause his symptoms, that the thickened heart muscle comes from high blood pressure and should improve with treatment, and that he can keep refereeing with the plan above. He was relieved, and asked that the medicines be generics he can afford; all three suggested are. [S]
- Follow-up: Cardiology review with the repeat echocardiogram in six to twelve months, or sooner for palpitations, fainting or new chest symptoms; Dr. Okafor-Rosenthal continues his blood pressure care. [S]